Comparison of Remnant-like Lipoprotein Particles in Postmenopausal Women with and Without Coronary Artery Disease and in Men with Coronary Artery Disease
Overview
Authors
Affiliations
It is known that hypertriglyceridemia is a risk factor of coronary artery disease (CAD) in postmenopausal women. This study prospectively examined whether remnant lipoprotein, an atherogenic triglyceride-rich lipoprotein, may have a significant risk and prognostic values in postmenopausal women with angiographically verified CAD. Remnant-like lipoprotein particles cholesterol (RLP cholesterol) levels in fasting serum were measured in 134 consecutive postmenopausal women with (n = 56) or without (n = 78) CAD by an immunoseparation method. The women with CAD were followed for < or =24 months until occurrence of the following clinical coronary events: readmission or coronary revascularization due to recurrent or refractory angina pectoris, nonfatal myocardial infarction, and cardiac death. Multivariate logistic regression analysis showed that high RLP cholesterol levels (>5.7 mg/dl cholesterol; 90th percentile of the distribution of RLP cholesterol levels in controls) were a significant risk factor for the presence of CAD independent of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, and other traditional risk factors. Kaplan-Meier analysis demonstrated that women with CAD and higher RLP cholesterol levels had a significantly higher probability of developing coronary events (p <0.001). In multivariate Cox hazard analysis, high RLP cholesterol levels as well as diabetes and hypercholesterolemia were a significant predictor of future coronary events independent of other risk factors in women with CAD (odds ratio 9.7, 95% confidence intervals 1.3 to 20.3, p = 0.02). In conclusion, increased levels of RLP cholesterol are a significant and independent risk factor of CAD and predict future coronary events in postmenopausal women with CAD.
Feng X, Guo Q, Zhou S, Sun T, Liu Y, Zhou Z Lipids Health Dis. 2020; 19(1):44.
PMID: 32178671 PMC: 7076918. DOI: 10.1186/s12944-020-01224-8.
How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?.
Welty F Curr Cardiol Rep. 2013; 15(9):400.
PMID: 23881582 PMC: 4465984. DOI: 10.1007/s11886-013-0400-4.
Lamon-Fava S, Herrington D, Reboussin D, Sherman M, Horvath K, Schaefer E Atherosclerosis. 2009; 205(1):325-30.
PMID: 19155011 PMC: 2700198. DOI: 10.1016/j.atherosclerosis.2008.12.020.
Remnant lipoproteins and atherosclerosis.
Twickler T, Dallinga-Thie G, Chapman M, Cohn J Curr Atheroscler Rep. 2005; 7(2):140-7.
PMID: 15727730 DOI: 10.1007/s11883-005-0037-x.